Evidence map›Paper›PMID 26612825›Full record

ArticleJournal of anatomy2016

Distinct expression patterns for type II topoisomerases IIA and IIB in the early foetal human telencephalon.

Lauren F Harkin, Dianne Gerrelli, Diana C Gold Diaz, Chloe Santos, Ayman Alzu'bi, Caroline A Austin, Gavin J Clowry

Open access · hybridAbstract read
In one paragraph

Article in Journal of anatomy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 52 citations in OpenAlex.

  1. DNA topological regulation in RNA polymerase II transcription.Cellular & molecular biology letters · 2026
    Review
  2. TOP2B is required for compartment strength changes upon retinoic acid treatment in SH-SY5Y cells.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Contributions of DNA Damage to Alzheimer's Disease.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lauren F HarkinInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Dianne GerrelliHDBR Resource, UCL Institute of Child Health, London, UK.
Diana C Gold DiazHDBR Resource, UCL Institute of Child Health, London, UK.
Chloe SantosHDBR Resource, UCL Institute of Child Health, London, UK.
Ayman Alzu'biInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Caroline A AustinInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK.
Gavin J ClowryInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Newcastle University · GBInstitute of Child Health · INUniversity College London · GB

Funding

Medical Research Council G0700089Medical Research Council MC_PC_15004Wellcome TrustWellcome Trust 099175/Z/12/Z
6 · The paper itself

Abstract

TOP2A and TOP2B are type II topoisomerase enzymes that have important but distinct roles in DNA replication and RNA transcription. Recently, TOP2B has been implicated in the transcription of long genes in particular that play crucial roles in neural development and are susceptible to mutations contributing to neurodevelopmental conditions such as autism and schizophrenia. This study maps their expression in the early foetal human telencephalon between 9 and 12 post-conceptional weeks. TOP2A immunoreactivity was restricted to cell nuclei of the proliferative layers of the cortex and ganglionic eminences (GE), including the ventricular zone and subventricular zone (SVZ) closely matching expression of the proliferation marker KI67. Comparison with sections immunolabelled for NKX2.1, a medial GE (MGE) marker, and PAX6, a cortical progenitor cell and lateral GE (LGE) marker, revealed that TOP2A-expressing cells were more abundant in MGE than the LGE. In the cortex, TOP2B is expressed in cell nuclei in both proliferative (SVZ) and post-mitotic compartments (intermediate zone and cortical plate) as revealed by comparison with immunostaining for PAX6 and the post-mitotic neuron marker TBR1. However, co-expression with KI67 was rare. In the GE, TOP2B was also expressed by proliferative and post-mitotic compartments. In situ hybridisation studies confirmed these patterns of expression, except that TOP2A mRNA is restricted to cells in the G2/M phase of division. Thus, during early development, TOP2A is likely to have a role in cell proliferation, whereas TOP2B is expressed in post-mitotic cells and may be important in controlling expression of long genes even at this early stage.

Indexed as

Antigens, NeoplasmDNA-Binding ProteinsDNA Topoisomerases, Type IIFetusHumansImmunohistochemistryIn Situ HybridizationNeurogenesisPoly-ADP-Ribose Binding ProteinsTelencephalonAntigens, NeoplasmDNA-Binding ProteinsDNA Topoisomerases, Type IIPoly-ADP-Ribose Binding ProteinsTOP2A protein, humanTOP2B protein, humanautism susceptibility genescortical developmentDNA replicationganglionic eminencesRNA transcription

Identifiers

PMID26612825
PMCPMC4832326
OpenAlexW2175027464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.